Individualising the dose of allopurinol in patients with gout-Reference-Cited by-同舟云学术

Individualising the dose of allopurinol in patients with gout

Published:2017-05-28 Issue:9 Volume:83 Page:2015-2026
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Kannangara Diluk R. W.¹²^ORCID,Graham Garry G.¹²,Wright Daniel F. B.³,Stocker Sophie L.¹²,Portek Ian⁴,Pile Kevin D.⁵,Barclay Murray L.⁶⁷,Williams Kenneth M.¹²,Stamp Lisa K.⁶,Day Richard O.¹²⁸

Affiliation:

1. Department of Clinical Pharmacology & Toxicology; St Vincent's Hospital; Sydney Australia

2. School of Medical Sciences; University of New South Wales; Sydney Australia

3. School of Pharmacy; University of Otago; Dunedin New Zealand

4. Department of Rheumatology; St George Hospital; Sydney Australia

5. Department of Medicine; Western Sydney University; Campbelltown Australia

6. Department of Medicine; University of Otago; Christchurch New Zealand

7. Department of Clinical Pharmacology; Christchurch Hospital; Christchurch New Zealand

8. St Vincent's Clinical School; University of New South Wales; Sydney Australia

Funder

National Health and Medical Research Council

Arthritis Australia

Lexy Davies Bequest

National Health and Medical Research Council Program

Arthritis Australia National Research

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13307/fullpdf

Reference36 articles.

1. The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands;Southan;Nucleic Acids Res,2016

2. The Concise guide to PHARMACOLOGY 2015/16: Enzymes;Alexander;Br J Pharmacol,2015

3. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol;Day;Clin Pharmacokinet,2007

4. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study;Campion;Am J Med,1987

5. Serum uric acid and the risk of incident and recurrent gout: a systematic review;Shiozawa;J Rheumatol,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a prediction nomogram for depressive symptoms in gout patients;Frontiers in Public Health;2024-07-19

2. Moving urate-lowering therapy in gout beyond guideline recommendations;Seminars in Arthritis and Rheumatism;2024-04

3. The development and evaluation of dose‐prediction tools for allopurinol therapy (Easy‐Allo tools);British Journal of Clinical Pharmacology;2024-02-15

4. Hepatic Safety of Febuxostat and Allopurinol for Gout Patients: A Systematic Review of Randomized Controlled Trial;Therapeutics and Clinical Risk Management;2023-09

5. Population pharmacokinetics, pharmacodynamics and pharmacogenetics modelling of oxypurinol in Hmong adults with gout and/or hyperuricemia;British Journal of Clinical Pharmacology;2023-06-04